RAMAT GAN, Israel--(BUSINESS WIRE)--Optimata Ltd. today announced the beginning of a new and expanded collaboration agreement with Eli Lilly & Co. The new collaboration follows the successful completion of a pilot collaboration project with Eli Lilly and involves targeting additional drug candidates. Financial details of the collaboration were not disclosed.
